To have the best tools for our drug analysis, we constantly optimize algorithms and pipelines and grow our distributed network which is a cost-efficient source for the needed computing power.
Neonious is contracted to help to assess a drug for safety and adverse reactions.
Besides manual analysis, Neonious' research team utilizes computational pipelines
These pipelines queue simulations (docking + MD) to be run by the Neonious Network, paid with MDSIMs.
Sombody running the Neonious software, thus being part of the Neonious Network, runs the simulations.
This person is rewarded with easy transferable MDSIMs, which he or her can exchange for real money.
We believe it is beneficial to reduce risks by contract us to analyse your drug, preferable before starting preclinical research, latest before phase 2 of the human trials.
For lower cost, we can utilize the Neonious Network. Alternatively, the calculations can also be done on more private computing resources
https://github.com/neonious/WelcomeToCodeRepository
25/05/2021
01/07/2021
01/09/2021
31/10/2021
01/11/2021
01/01/2022
Early 2022
Verified 0%
Attention. There is a risk that unverified members are not actually members of the team
This offer is based solely on information provided by the offeror and other publicly available sources.
The token sale or exchange event is completely independent of ICOholder. ICOholder is not involved in any way, including technical support or promotion.
We list token sales from entities with which we have no relationship to help users track overall activity within the token sector. This information is not intended as advice, and you should seek professional or specialist guidance or conduct your own due diligence before making any decisions based on our content.
Any terms and conditions regarding token acquisition are solely between contributors and the token issuer. ICOholder is not the seller of these tokens.
ICOholder is not legally responsible for any representations made by third parties about any token sale. Any claims for breach of contract must be directed against the listed token issuing entity.
If you have concerns about the nature, legality, or propriety of a token sale or the involved individuals, please contact info@icoholder.com with detailed information.